J.M. Bauml

Springhouse

Publishes on Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Gastric Cancer Management and Outcomes. 5 papers and 57 citations.

5Publications

57Total Citations

Lung Cancer Treatments and Mutations Colorectal Cancer Treatments and Studies Gastric Cancer Management and Outcomes Hepatocellular Carcinoma Treatment and Prognosis Lung Cancer Diagnosis and Treatment

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

LBA55 Mechanisms of acquired resistance to first-line amivantamab plus lazertinib versus osimertinib in patients with EGFR-mutant advanced non-small cell lung cancer: An early analysis from the phase III MARIPOSA study

B. Besse, SH Lee, Shun Lü et al.|Annals of Oncology|2024

Cited by 42Open Access

P1.16-01 Amivantamab and Lazertinib in Treatment-Naive EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

B.C. Cho, S.-H. Lee, J.-Y. Han et al.|Journal of Thoracic Oncology|2022

Cited by 7

MA07.04 Amivantamab and Lazertinib in Combination with Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC

M.E. Marmarelis, S.-H. Lee, Alexander I. Spira et al.|Journal of Thoracic Oncology|2022

Cited by 4

MA13.06 Amivantamab, Lazertinib Plus Platinum-based Chemotherapy in EGFR-mutated Advanced NSCLC: Updated Results from CHRYSALIS-2

S.-H. Lee, Byoung Chul Cho, Alexander I. Spira et al.|Journal of Thoracic Oncology|2023

Cited by 4Open Access

EP.12H.02 Amivantamab, An EGFR-MET Bispecific Antibody, with Cetrelimab, An Anti-PD-1 Antibody, In Advanced NSCLC: Phase 1/2 Polydamas

P.J. Voon, Ju Le Tan, A.I. Spira et al.|Journal of Thoracic Oncology|2024

Cited by 1Open Access